Cyclo Therapeutics Shares Jump After Filing To Start Alzheimer's Trial In US
Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimer's Where Competitors Fail
Cyclo Therapeutics Shares Jump After Filing To Start Alzheimer's Trial In US
Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimer's Where Competitors Fail
New Upside Potential Drives JPMorgan's Eli Lilly Upgrade
FDA Approves Adamas Pharmaceuticals' Alzheimer's Drug, Shares Soar